Androgen-regulated metabolism and biosynthesis in prostate cancer

Endocrine-Related Cancer

Volumn 21, Issue 4, 2014, Pages

  Barfeld, Stefan J ^a   Itkonen, Harri M ^a   Urbanucci, Alfonso ^a   Mills, Ian G ^a,b,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Cancer Registry of Norway   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Androgen; Androgen receptor; Molecular biology; Oncogene; Prostate

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; PROTEIN P53;

ANDROGEN METABOLISM; BINDING SITE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; FEEDBACK SYSTEM; GENE REGULATORY NETWORK; GENE TARGETING; HUMAN; LIPID METABOLISM; NONHUMAN; ONCOGENE C MYC; PHYSIOLOGICAL STRESS; PROSTATE; PROSTATE CANCER; REGULATORY MECHANISM; REVIEW; STEROIDOGENESIS; UNFOLDED PROTEIN RESPONSE; ANIMAL; ENDOPLASMIC RETICULUM; MALE; METABOLISM; PROSTATE TUMOR;

ANDROGENS; ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STRESS, PHYSIOLOGICAL; UNFOLDED PROTEIN RESPONSE;

EID: 84905974953     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0515     Document Type: Review

References (95)

1. Akhavan-Niaki H & Samadani AA 2013 DNA methylation and cancer development: molecular mechanism. Cell Biochemistry and Biophysics 67 501-513. (doi:10.1007/s12013-013-9555-2)
2. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE & Means AR 2008 Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metabolism 7 377-388. (doi:10.1016/j.cmet. 2008.02.011)
3. Berwick DC, Hers I, Heesom KJ, Moule SK & Tavare JM 2002 The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. Journal of Biological Chemistry 277 33895-33900. (doi:10.1074/jbc.M204681200)
4. Blandino G, Levine AJ & Oren M 1999 Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 18 477-485. (doi:10.1038/sj.onc.1202314)
5. Bonkhoff H & Remberger K 1993 Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Archiv. A, Pathological Anatomy and Histopathology 422 35-38. (doi:10.1007/BF01605130)
6. Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E et al. 2013 Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. International Review of Cell and Molecular Biology 301 215-290. (doi:10.1016/B978-0-12-407704- 1.00005-1)
7. Brenner C, Deplus R, Didelot C, Loriot A, Vire E, De Smet C, Gutierrez A, Danovi D, Bernard D, Boon T et al. 2005 Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO Journal 24 336-346. (doi:10.1038/sj.emboj.7600509)
8. Brodsky JL 2012 Cleaning up: ER-associated degradation to the rescue. Cell 151 1163-1167. (doi:10.1016/j.cell.2012.11.012)
9. Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H et al. 2011 Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell 19 575-586. (doi:10.1016/j.ccr.2011.04.008)
10. Chou TY, Dang CV & Hart GW 1995a Glycosylation of the c-Myc transactivation domain. PNAS 92 4417-4421. (doi:10.1073/pnas.92.10.4417)
11. Chou TY, Hart GW & Dang CV 1995b c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. Journal of Biological Chemistry 270 18961-18965. (doi:10.1074/jbc.270.32.18961)
12. Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, Leung IK, Li XS, Woon EC, Yang M et al. 2011 The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Reports 12 463-469. (doi:10.1038/embor.2011.43)
13. Cohen RJ, McNeal JE, Edgar SG, Robertson T & Dawkins HJ 1998 Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma. Human Pathology 29 1488-1494. (doi:10.1016/S0046-8177(98)90020- X)
14. Costello LC & Franklin RB 1981 Aconitase activity, citrate oxidation, and zinc inhibition in rat ventral prostate. Enzyme 26 281-287. (Pubitemid 12194610)
15. Cronauer MV, Schulz WA, Burchardt T, Ackermann R & Burchardt M 2004 Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines. Oncogene 23 3541-3549. (doi:10.1038/sj.onc.1207346)
16. Dahl E 1976 The ultrastructure of the accessory sex organs of themale rat. XI. Nuclear alterations of prostatic epithelial cells induced by castration. Cell and Tissue Research 171 285-296. (doi:10.1007/BF00224654)
17. DeBerardinis RJ, Lum JJ, Hatzivassiliou G & Thompson CB 2008 The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metabolism 7 11-20. (doi:10.1016/j.cmet.2007.10.002)
18. Desouki MM, Geradts J, Milon B, Franklin RB & Costello LC 2007 hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Molecular Cancer 6 37. (doi:10.1186/1476-4598-6-37)
19. Elsberger B, Lankston L, Orange C, Underwood MA & Edwards J 2010 Expression of hypoxia inducible factor-1α in matched hormone naive and castrate resistant prostate cancer specimens. Cancer Biomarkers: Section A of Disease Markers 8 1-9. (doi:10.3233/DMA-2011-0805)
20. Ford WC & Harrison A 1984 The role of citrate in determining the activity of calcium ions in human semen. International Journal of Andrology 7 198-202. (doi:10.1111/j.1365-2605.1984.tb00777.x)
21. Franklin RB, Feng P, Milon B, Desouki MM, Singh KK, Kajdacsy-Balla A, Bagasra O & Costello LC 2005 hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Molecular Cancer 4 32. (doi:10.1186/1476-4598-4-32)
22. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT et al. 2009 c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458 762-765. (doi:10.1038/nature07823)
23. Gardner BM, Pincus D, Gotthardt K, Gallagher CM & Walter P 2013 Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harbor Perspectives in Biology 5 a013169. (doi:10.1101/cshperspect. a013169)
24. Ghiam AF, Cairns RA, Thoms J, Dal Pra A, Ahmed O, Meng A, Mak TW & Bristow RG 2012 IDH mutation status in prostate cancer. Oncogene 31 3826. (doi:10.1038/onc.2011.546)
25. Gordan JD, Thompson CB & Simon MC 2007 HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12 108-113. (doi:10.1016/j.ccr.2007.07.006)
26. Gorlov IP, Byun J, Gorlova OY, Aparicio AM, Efstathiou E & Logothetis CJ 2009 Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data. BMC Medical Genomics 2 48. (doi:10.1186/1755-8794-2-48)
27. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC et al. 2012 The mutational landscape of lethal castration-resistant prostate cancer. Nature 487 239-243. (doi:10.1038/ nature11125)
28. Grummt I 2013 The nucleolus - guardian of cellular homeostasis and genome integrity. Chromosoma 122 487-497. (doi:10.1007/s00412-013-0430-0)
29. Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674. (doi:10.1016/j.cell.2011.02.013)
30. Hanover JA, Krause MW & Love DC 2010 The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochimica et Biophysica Acta 1800 80-95. (doi:10.1016/j.bbagen.2009.07.017)
31. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M et al. 2012 ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. Journal of Clinical Investigation 122 4621-4634. (doi:10.1172/JCI62973)
32. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA & Thompson CB 2005 ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8 311-321. (doi:10.1016/j.ccr.2005.09. 008)
33. Hawksworth D, Ravindranath L, Chen Y, Furusato B, Sesterhenn IA, McLeod DG, Srivastava S & Petrovics G 2010 Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence. Prostate Cancer and Prostatic Diseases 13 311-315. (doi:10.1038/pcan.2010.31)
34. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG & Hardie DG 2005 Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2 9-19. (doi:10.1016/j.cmet.2005.05.009)
35. Heemers H, Vanderhoydonc F, Roskams T, Shechter I, Heyns W, Verhoeven G & Swinnen JV 2003 Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Molecular and Cellular Endocrinology 205 21-31. (doi:10.1016/S0303-7207(03)00205-3)
36. Hensley CT, Wasti AT & DeBerardinis RJ 2013 Glutamine and cancer: cell biology, physiology, and clinical opportunities. Journal of Clinical Investigation 123 3678-3684. (doi:10.1172/JCI69600)
37. Higa A, Mulot A, Delom F, Bouchecareilh M, Nguyen DT, Boismenu D, Wise MJ & Chevet E 2011 Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 (AGR2) in the control of endoplasmic reticulum homeostasis. Journal of Biological Chemistry 286 44855-44868. (doi:10.1074/jbc.M111.275529)
38. Hollstein M, Sidransky D, Vogelstein B & Harris CC 1991 p53 mutations in human cancers. Science 253 49-53. (doi:10.1126/science.1905840)
39. Hsu PP & Sabatini DM 2008 Cancer cell metabolism: Warburg and beyond. Cell 134 703-707. (doi:10.1016/j.cell.2008.08.021)
40. Hu W, Zhang C, Wu R, Sun Y, Levine A & Feng Z 2010 Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. PNAS 107 7455-7460. (doi:10.1073/pnas.1001006107)
41. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T & Mills IG 2013 O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Research 73 5277-5287. (doi:10.1158/0008-5472.CAN-13-0549)
42. Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M & Jung K 2010 Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. European Urology 58 12-18 (discussion 20-21). (doi:10.1016/j.eururo. 2010.01.035)
43. Jiang P, Du W, Wang X, Mancuso A, Gao X, Wu M & Yang X 2011 p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology 13 310-316. (doi:10.1038/ncb2172)
44. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA et al. 2013 Mutational landscape and significance across 12 major cancer types. Nature 502 333-339. (doi:10.1038/nature12634)
45. Kastan MB & Berkovich E 2007 p53: a two-faced cancer gene. Nature Cell Biology 9 489-491. (doi:10.1038/ncb0507-489)
46. Kim JW, Zeller KI,Wang Y, Jegga AG, Aronow BJ, O'Donnell KA & Dang CV 2004 Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Molecular and Cellular Biology 24 5923-5936. (doi:10.1128/MCB.24.13.5923-5936.2004)
47. Kokontis J, Takakura K, Hay N & Liao S 1994 Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Research 54 1566-1573. (Pubitemid 24106424)
48. Kusakabe T, Maeda M, Hoshi N, Sugino T, Watanabe K, Fukuda T & Suzuki T 2000 Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells. Journal of Histochemistry and Cytochemistry 48 613-622. (doi:10.1177/002215540004800505)
49. Lamont KR & Tindall DJ 2010 Androgen regulation of gene expression. Advances in Cancer Research 107 137-162. (doi:10.1016/S0065-230X(10)07005-3)
50. Li S, Hu MG, Sun Y, Yoshioka N, Ibaragi S, Sheng J, Sun G, Kishimoto K & Hu GF 2013 Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance. Molecular Cancer Research 11 1203-1214. (doi:10.1158/1541-7786.MCR-13-0072)
51. Lloyd MD, Darley DJ, Wierzbicki AS & Threadgill MD 2008 α-Methylacyl-CoA racemase - an 'obscure' metabolic enzyme takes centre stage. FEBS Journal 275 1089-1102. (doi:10.1111/j.1742-4658.2008.06290.x)
52. Mainwaring WI & Derry NS 1983 Enhanced transcription of rRNA genes by purified androgen receptor complexes in vitro. Journal of Steroid Biochemistry 19 101-108. (doi:10.1016/S0022-4731(83)80012-0)
53. Marberger H, Marberger E, Mann T & Lutwak-Mann C 1962 Citric acid in human prostatic secretion and metastasizing cancer of prostate gland. BMJ 1 835-836. (doi:10.1136/bmj.1.5281.835)
54. Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC & Fleshner N 2013 Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes. Journal of Clinical Oncology 31 3069-3075. (doi:10.1200/JCO.2012.46.7043)
55. Massie CE & Mills IG 2012 Mapping protein-DNA interactions using ChIP-sequencing. Methods in Molecular Biology 809 157-173. (doi:10.1007/978-1- 61779-376-9-11)
56. Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, Warren A, Scott H, Madhu B, Sharma N et al. 2011 The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO Journal 30 2719-2733. (doi:10.1038/emboj.2011.158)
57. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G, Inazuka F, Grisanzio C, Palescandolo E, Shin E et al. 2009 Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. Journal of the National Cancer Institute 101 519-532. (doi:10.1093/jnci/djp030)
58. Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L, Hu Y, Fabre C, Minami J, Ohguchi H et al. 2012 Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma. Blood 119 5772-5781. (doi:10.1182/blood-2011-07-366633)
59. Nikiforov MA, Chandriani S, O'Connell B, Petrenko O, Kotenko I, Beavis A, Sedivy JM & Cole MD 2002 A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Molecular and Cellular Biology 22 5793-5800. (doi:10.1128/MCB.22.16.5793-5800.2002)
60. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK & Sedivy JM 2003 A large scale genetic analysis of c-Myc-regulated gene expression patterns. Journal of Biological Chemistry 278 12563-12573. (doi:10.1074/jbc. M210462200)
61. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA & Dang CV 2000 Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. Journal of Biological Chemistry 275 21797-21800. (doi:10.1074/jbc.C000023200)
62. Ottaviani S, Brooke GN, O'Hanlon-Brown C, Waxman J, Ali S & Buluwela L 2013 Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells. Journal of Molecular Endocrinology 51 301-312. (doi:10.1530/JME-13-0169)
63. Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R & Lichter P 2013 Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nature Reviews. Genetics 14 765-780. (doi:10.1038/nrg3554)
64. Pritchard CC & Nelson PS 2008 Gene expression profiling in the developing prostate. Differentiation 76 624-640. (doi:10.1111/j.1432-0436.2008. 00274.x)
65. Rajan P, Dalgliesh C, Carling PJ, Buist T, Zhang C, Grellscheid SN, Armstrong K, Stockley J, Simillion C, Gaughan L et al. 2011 Identification of novel androgen-regulated pathways and mRNA isoforms through genome-wide exon-specific profiling of the LNCaP transcriptome. PLoS ONE 6 e29088. (doi:10.1371/journal.pone.0029088)
66. Ranasinghe WK, Xiao L, Kovac S, Chang M, Michiels C, Bolton D, Shulkes A, Baldwin GS & Patel O 2013 The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers. PLoS ONE 8 e54251. (doi:10.1371/journal.pone.0054251)
67. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D & Chinnaiyan AM 2002 α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Journal of the American Medical Association 287 1662-1670. (doi:10.1001/jama.287.13.1662)
68. Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW et al. 2002 Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21 8749-8758. (doi:10.1038/sj.onc.1205992)
69. Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R, Warren AY, Mills IG et al. 2013 The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell 23 35-47. (doi:10.1016/j.ccr.2012.11.010)
70. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R & Dang CV 1997 c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. PNAS 94 6658-6663. (doi:10.1073/pnas.94.13.6658)
71. Singh KK, Desouki MM, Franklin RB & Costello LC 2006 Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Molecular Cancer 5 14. (doi:10.1186/1476-4598-5-14)
72. Slawson C, Copeland RJ & Hart GW2010 O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends in Biochemical Sciences 35 547-555. (doi:10.1016/j.tibs.2010.04.005)
73. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y et al. 2009 Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 910-914. (doi:10.1038/nature07762)
74. Suh DH, Kim MK, Kim HS, Chung HH & Song YS 2012 Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Annals of the New York Academy of Sciences 1271 20-32. (doi:10.1111/j.1749-6632. 2012.06739.x)
75. Swinnen JV, Esquenet M, Goossens K, Heyns W & Verhoeven G 1997 Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Research 57 1086-1090. (Pubitemid 27138606)
76. Tan SS, Ahmad I, Bennett HL, Singh L, Nixon C, Seywright M, Barnetson RJ, Edwards J & Leung HY 2011 GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer. Journal of Pathology 223 81-87. (doi:10.1002/path.2795)
77. Thompson TC 2011 Turning reciprocal feedback regulation into combination therapy. Cancer Cell 19 697-699. (doi:10.1016/j.ccr.2011.05.022)
78. Thompson TC, Park SH, Timme TL, Ren C, Eastham JA, Donehower LA, Bradley A, Kadmon D & Yang G 1995 Loss of p53 function leads to metastasis in ras + myc-initiated mouse prostate cancer. Oncogene 10 869-879.
79. Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI & Sidransky D 2004 Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clinical Cancer Research 10 5518-5522. (doi:10.1158/1078-0432.CCR-04-0108)
80. 2+/calmodulin-dependent protein kinase kinase. Journal of Biological Chemistry 277 15813-15818. (doi:10.1074/jbc.M201075200)
81. Towler MC & Hardie DG 2007 AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 100 328-341. (doi:10.1161/01.RES.0000256090.42690.05)
82. Vander Heiden MG, Cantley LC & Thompson CB 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 1029-1033. (doi:10.1126/science.1160809)
83. Vousden KH 2010 Alternative fuel - another role for p53 in the regulation of metabolism. PNAS 107 7117-7118. (doi:10.1073/pnas.1002656107)
84. Wagner C & Luka Z 2011 Sarcosine, folate metabolism and prostate cancer - is there a link? Journal of Urology 185 385-386. (doi:10.1016/j.juro. 2010.11.019)
85. Wang YC, Tang FY, Chen SY, Chen YM & Chiang EP 2011 Glycine-N methyltransferase expression in HepG2 cells is involved inmethyl group homeostasis by regulating transmethylation kinetics and DNA methylation. Journal of Nutrition 141 777-782. (doi:10.3945/jn.110.135954)
86. Warburg O, Wind F & Negelein E 1927 The metabolism of tumors in the body. Journal of General Physiology 8 519-530. (doi:10.1085/jgp.8.6.519)
87. Wayner EA, Quek SI, Ahmad R, Ho ME, Loprieno MA, Zhou Y, Ellis WJ, True LD & Liu AY 2012 Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine. Prostate 72 1023-1034. (doi:10.1002/pros.21508)
88. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR &Thompson CB 2009 ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 1076-1080. (doi:10.1126/science.1164097)
89. Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, Nissim I, Daikhin E, Yudkoff M, McMahon SB et al. 2008 Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. PNAS 105 18782-18787. (doi:10.1073/pnas.0810199105)
90. Wu Y, Chhipa RR, Cheng J, Zhang H, Mohler JL & Ip C 2010 Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival. Anticancer Research 30 3895-3901.
91. Wu D, Zhang C, Shen Y, Nephew KP & Wang Q 2011 Androgen receptor-driven chromatin looping in prostate cancer. Trends in Endocrinology and Metabolism 22 474-480. (doi:10.1016/j.tem.2011.07.006)
92. Yuneva M, Zamboni N, Oefner P, Sachidanandam R & Lazebnik Y 2007 Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. Journal of Cell Biology 178 93-105. (doi:10.1083/jcb.200703099)
93. Yuneva MO, Fan TW, Allen TD, Higashi RM, Ferraris DV, Tsukamoto T, Mates JM, Alonso FJ, Wang C, Seo Y et al. 2012 The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metabolism 15 157-170. (doi:10.1016/j.cmet.2011.12.015)
94. Zaidi N, Swinnen JV & Smans K 2012 ATP-citrate lyase: a key player in cancer metabolism. Cancer Research 72 3709-3714. (doi:10.1158/0008-5472.CAN-11- 4112)
95. Zawacka-Pankau J, Grinkevich VV, Hunten S, Nikulenkov F, Gluch A, Li H, Enge M, Kel A & Selivanova G 2011 Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer. Journal of Biological Chemistry 286 41600-41615. (doi:10.1074/jbc.M111.240812)